Early antiproteinuric effect of voclosporin in patients with lupus nephritis in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience. (PubMed, Rheumatology (Oxford)) - Dec 13, 2025 - "Voclosporin may provide a valuable therapeutic option in LN management, achieving early 24 h-proteinuria response consistent with clinical trial data."
Journal • Cardiovascular • Glomerulonephritis • Hypertension • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Pulmonary Arterial Hypertension • Renal Disease • Rheumatology • Systemic Lupus Erythematosus
|
|
Alessandra Bortoluzzi; Andrea Doria; Aurora Di Gregorio; Cinzia Ferio; Daniela Picciotto; Domenico Santoro; Ettore Silvagni; Filippo Vesentini; Francesca Ruzzon; Francesco Gozza; Franco Franceschini; Gabriella Moroni; Giacomo Emmi; Ginevra De Marchi; Giorgio Buscetta; Giovanni Orsolini; Giulia Pazzola; Giuliana Marongiu; Luca Iaccarino; Luca Quartuccio; Marco Allinovi; Margherita Zen; Marta Calatroni; Micaela Fredi; Paola Tomietto; Paride Fenaroli; Pasquale Esposito; Rossella De Angelis
|